MARYLAND INDUSTRIAL PARTNERSHIPS

MIPS Projects

Projects Home
Filter by:

County

Technologies

Round

Year

Campus

Reset Filters

MIPS Round 

60

August

 

2017

August 1, 2017

Vasoptic Medical, Inc.

Baltimore

 | 

Baltimore City

 County

Project:

XyCAM Based Diagnostics

Principal Investigator:

Osamah
 
Saeedi
Associate Professor, Department of Ophthalmology and Visual Sciences

Technologies:

Medical Instrumentation / Equipment

Vasoptic Medical Inc. is a medical device company developing and commercializing high-quality, cost-effective products for the non invasive, dynamic assessment of retinal blood flow and vascular status. Vasoptic Medical has developed a low-cost, portable, noninvasive retinal imaging instrument (the XyCAM), which can complement fundus photographs with retinal blood flow information obtained at high spatio-temporal resolution without the introduction of any dyes. This handheld retinal imager has the potential to help detect a number of clinical conditions, including diabetic retinopathy (DR), glaucoma, and age-related macular degeneration. Early detection can often prevent vision loss. The XyCAM device is being designed to detect these conditions inn their earliest stages to help healthcare providers manage and prevent DR and glaucoma progression through a convenient, low-cost, minimally invasive procedure.

Vasoptic has raised over $3 million in funding to date.

MIPS helped my company achieve first-in-human images of retinal blood flow using our handheld XyCAM retinal imager, a key milestone in the development of a low-cost, portable retinal imager for disease diagnostics.

MIPS Round 

60

August

 

2017

August 1, 2017

Abilis Life Sciences Inc.

Potomac

 | 

Montgomery

 County

Project:

Bladder Cancer Diagnostic Signature Validation

Principal Investigator:

Mohummad Minhaj
 
Siddiqui
Assistant Professor of Surgery, Urology, University of Maryland Medical Center

Technologies:

Biotechnology / Genetic Engineering

Abilis LS is developing a non-invasive, accurate, sensitive and specific diagnostic staging test for bladder cancer. The company’s bladder cancer test has the potential to be quickly incorporated into the routine urinalysis of all adult male and female patients with hematuria, as well as for the surveillance of recurrence and progression in patients with a history of non-muscle, invasive bladder cancer (NMIBC).

MIPS Round 

60

August

 

2017

August 1, 2017

JPLC Associates, LLC

Towson

 | 

Baltimore City

 County

Project:

Filmless HDR QA Using RavenQA

Principal Investigator:

Byongyong
 
Yi
Professor, Director of Proton Physics

Technologies:

Medical Instrumentation / Equipment

MIPS Round 

59

February

 

2017

February 1, 2017

MastiX LLC

Hunt Valley

 | 

Baltimore

 County

Project:

Treating Gingivitis with a Functional Chewing Gum

Principal Investigator:

Harlan
 
Shiau
Clinical Associate Professor, Department of Periodontology

Technologies:

Biotechnology / Genetic Engineering

Mastix LLC develops and manufactures niche healthcare products such as tableted chewing gum, chewable tablets and lozenges. Mastix is one of only a few companies in the world (and the only one in the U.S.) that has the ability to make tableted chewing gum products at room temperature versus the traditional high-heat process, which degrades active ingredients and reduces their efficacy. Mastix can also create custom formulations.

MIPS helped my company fund a clinical study for a firstof-its-kind product that will provide relief to millions of consumers seeking a convenient and easy-to-use solution to the common and wide-spread dental problem of gingivitis.
This study could provide the data for the FDA to evaluate the regulatory path for BEC Gum to make an application as a medical device, which would make it the first of its kind, and provide a strong label for better commercialization. Gingivitis and periodontal disease affects about 50 percent of adults over the age of 30, according to the 2009–2010 National Health and Nutrition Examination Survey. (Source: MastiX LLC)

MIPS Round 

59

February

 

2017

February 1, 2017

38° North, LLC

Ridge

 | 

Saint Mary’s

 County

Project:

Advancing oyster settlement for aquaculture

Principal Investigator:

Thomas
 
Miller
Professor and Director, Chesapeake Biological Laboratory

Technologies:

Aquaculture

38° North LLC is a fully integrated oyster grow-out company, with activities spanning nursery operations, grow-out, packaging, marketing and the shipping of oysters throughout the United States. While modest in size, 38 North is currently one of the largest producers of aquaculture oysters in Maryland.

MIPS helped my compan understand the factors involved in setting larvae so we have a more efficient and voluminous oyster seed production system, which in turn will allow for more market-sized oysters produced at lower costs.

MIPS Round 

59

February

 

2017

February 1, 2017

ZyGood, LLC

Dayton

 | 

Howard

 County

Project:

Design Optimization of Magnetic Pain-Relief Device

Principal Investigator:

Chandrasekhar
 
Thamire
Principal Lecturer

Technologies:

Medical Instrumentation / Equipment

MIPS Round 

59

February

 

2017

February 1, 2017

Transmucosis LLC

Clarksville

 | 

Howard

 County

Project:

FcRn-targeted mucosal vaccination

Principal Investigator:

Xiaoping
 
Zhu
Professor Associate Dean Department Chair Depart

Technologies:

Biotechnology / Genetic Engineering

MIPS Round 

59

February

 

2017

February 1, 2017

Quidient, LLC

Easton

 | 

Talbot

 County

Project:

Cognitive Inspection of Hail Damaged Automobiles

Principal Investigator:

Larry
 
Davis
Professor

Technologies:

Image Processing / Pattern Recognition

MIPS Round 

59

February

 

2017

February 1, 2017

BondTrue, LLC

Towson

 | 

Baltimore

 County

Project:

BondTrue Prototype Design and Development

Principal Investigator:

Hugh
 
Bruck
Professor, Department of Mechanical Engineering

Technologies:

Biotechnology / Genetic Engineering

BondTrue has developed a patented medical device that automates the process of surgical incisions and closures. The result is a fast, precise surgical wound that can be rapidly approximated and repaired. This significantly reduces surgical times and ensures excellent wound repair. Precise wound repair is associated with reduced scarring and decreased wound complications, including surgical wound infections.

BondTrue brings mechanical precision to a surgical process historically done by hand with the naked eye. The MIPS program has enabled collaboration between surgeons and engineers at the top of their fields, resulting in innovative breakthroughs. When the project is completed, BondTrue will raise capital to bring the product to market.

Collaborating with Hugh Bruck and his talented team of researchers has been pivotal for BondTrue’s progress. Using cutting-edge technology, including the latest 3-D printing technology in the mechanical engineering laboratory of the University of Maryland, has greatly advanced our prototype design, enabling us to accelerate the commercialization process.

MIPS Round 

59

February

 

2017

February 1, 2017

ATP-MD, LLC

Salisbury

 | 

Wicomico

 County

Project:

ATP-MD’s CRBBP Process–Extracting Excess Phosphorus from the Chesapeake Bay Watershed Farm Soils, While Making Bio-Products

Principal Investigator:

Arthur
 
Allen
Professor, Department of Agriculture, Food & Resource Sciences

Technologies:

Agriculture / Poultry Science

Environmental Technology / Science

ATP-MD LLC is the Maryland operating affiliate of Agri-Tech Producers LLC (ATP), a South Carolina-based, tech holding company. ATP has given ATP-MD exclusive rights to use ATP’s technologies in Maryland. ATP has a patent-pending Combined Remediation Biomass and Bio-Product Production (CRBBP) Process, along with a license to patented torrefaction technology developed by NC State University (NCSU).

ATP’s CRBBP process multi-tasks bio-crops and their resulting biomass to remediate soils and waters and to then make environmentally beneficial bio-products.

ATP’s torrefaction process is a form of mild pyrolysis, which heats biomass (animal, plant and woody material), in the absence of oxygen, changing it into a carbon-rich, energy-dense, dry and hydrophobic material that is easily ground into fine particles.

With the help of other UMD researchers, we are now planning on tweaking some of our bio-products, so they will be part of the “circular economy” and never end up as waste.
MIPS helped my company with critical R&D resources to help demonstrate our process, as well as attract additional resources and customers.

MIPS Round 

59

February

 

2017

February 1, 2017

Crab Machinery, LLC

Cambridge

 | 

Dorchester

 County

Project:

Crab Automation Machinery

Principal Investigator:

Yang
 
Tao
Professor, Fischell Department of Bioengineering

Technologies:

Food Processing

Crab Machinery is an engineering design, production and sales company dedicated to developing crab meat processing machines for crab meat processors.

No crab processing machinery has been able to “pick” jumbo lump to date.

MIPS Round 

59

February

 

2017

February 1, 2017

3i Diagnostics, Inc.

Germantown

 | 

Montgomery

 County

Project:

Isolation of intact bacteria from blood for an RDT

Principal Investigator:

Don
 
DeVoe
Professor, Department of Mechanical Engineering

Technologies:

Medical Instrumentation / Equipment

3i Diagnostics provides technology that enables physicians to identify infectious microbes within an hour, while leaving them intact for further testing. Physicians can then prescribe the right life-saving medications quickly, which reduces the cost of care and prevents the overprescribing that hastens the spread of drug-resistant bacteria.

Every hour, 50 people around the world die of sepsis. This medical emergency, driven by blood infection, attacks 30 million people each year—and can kill within 24 hours.

If physicians administer the right targeted antimicrobial drug to the patient within the first hour of sepsis onset, the survival rate is 80 percent.  After ten hours, the survival rate plummets to about 30 percent—even in advanced healthcare systems. The proliferation of antimicrobial resistant strains is why the correct, targeted antimicrobial must be chosen from the start.

3i Diagnostics’ ultimate goal is to provide physicians and clinical researchers with detailed information on all strains of microbes found in human blood, sputum, and other bodily fluids. Physicians can then rapidly prescribe the right medications.

Research conducted at the University of Maryland provided the means to fabricate microfluidic elements that aid in isolating intact bacteria directly from blood.  This project advances the results from this study by optimizing the operating and fabrication conditions of this component to aid in commercializing the diagnostic.

Dr. DeVoe and MIPS are driving our technology to new levels by helping to create a solution that is faster, more affordable and scalable.

MIPS Round 

59

February

 

2017

February 1, 2017

The Low Impact Development Design Group, Inc.

Silver Spring

 | 

Montgomery

 County

Project:

LIDMIX and LIDMAT for Industrial Stormwater

Principal Investigator:

Allen
 
Davis
Professor, Civil and Environmental Engineering

Technologies:

Environmental Technology / Science

The Low Impact Development Design Group, or LIDDG, manufactures and distributes two storm water best management practice (BMP) product lines.

LIDMIX is a media that is designed to treat the heavy metals zinc (Zn), copper (Cu), and lead (Pb), as well as other metals and non-point source runoff stormwater pollutants. The media can be used in existing media-based stormwater treatment devices, such as cartridges and filters, to enhance their performance.

The other product is LIDMAT™, for which LIDMIX™ media is inserted into a geotextile mat that is formed into modules that can be attached to each other to treat sheet flow or attached to a storm drain structure. A biodegradable version of the LIDMAT™ is also available. It can be planted with hyper accumulators, which will enhance the capture of pollutants.

MIPS Round 

59

February

 

2017

February 1, 2017

Manta Biofuel Inc.

Reisterstown

 | 

Baltimore

 County

Project:

Treating Algae to Reduce NOx Emissions in Biocrude

Principal Investigator:

Russell
 
Hill
Professor and Director, Institute of Marine and Environmental Technology

Technologies:

Energy

Manta Biofuel is a producer of renewable algal crude oil that is cost-competitive with traditional crude oil. The company employs technological advantages in a three-step process to produce crude oil from algae. The first is growing algae. Manta can convert algae from any source, leaving options open from farming to collecting natural blooms. For the second step, harvesting the algae, Manta uses a proprietary magnetic harvester that efficiently collects and concentrates algae. The company then converts the algae to crude oil through hydrothermal liquefaction (HTL).

MIPS helped my company perform research that would otherwise be impossible for our small startup to accomplish. The partnership with University of Maryland provided access to highly trained personnel and well-equipped laboratories.
Manta’s end product is crude oil (petroleum), largely equivalent to the product that is retrieved through underground drilling and later processed at refineries to produce materials such as gasoline, diesel, kerosene (related jet fuels), lubricating oils and tar. Currently, almost all crude oil consumed originates from non-renewable fossil fuels. Manta’s novel harvesting technology has the potential to drive down the cost of producing renewable crude oil to the point that it is competitive with or cheaper than fossil fuel-based crude oil, while at the same time being carbon-neutral.

MIPS Round 

59

February

 

2017

February 1, 2017

Whisker Labs

Germantown

 | 

Montgomery

 County

Project:

Economic Demand Response Stochastic Optimization

Principal Investigator:

Steven
 
Gabriel
Professor

Technologies:

Energy

Whisker Labs has built an energy management platform, Connected SavingsSM, which is an intelligent demand side management (IDSM) system that ties homes with utilities, big weather data and analytics to save energy—for customers, utilities and retail energy providers. The solution combines connected thermostats with proprietary weather information and thermodynamic models, developed in part with the University of Maryland, that predict how homes will respond to changing weather conditions, thus correlating energy usage to weather. Homes can then be intelligently precooled and setback, keeping customers comfortable while shifting loads for utilities during peak load events (DR events).

Over several years and several studies, the Connected Savings solution has outperformed similar, competing energy demand-response products by 15-20 percent. Additionally, homes have seen a 10 percent average HVAC energy saving for participating homes through thermostat efficiency adjustments, often over $100 in savings. Recently, Whisker Labs was ranked as the #2 residential demand response provider in the prestigious Navigant Research Leaderboard: Residential Demand Response report.

Currently, over 100,000 customers across the U.S. are using Whisker Labs’ home energy system, while approximately 20 utility partners are using Connected Savings in Texas, California, New England, and Maryland.

Siemann joined Whisker Labs after graduating, as have an additional four previous UMD engineering graduate students. In addition, the Whisker Labs Connected Savings team has grown from four employees prior to the MIPS grant, to nearly 30 here in Maryland.

Starting in January, 2017, Whisker Labs commenced a new MIPS project with mechanical engineering Professor Steven Gabriel, to study the potential economic benefits of DR for retail energy providers through the use of the Connected Savings solution and advanced setpoint scheduling. The research team also still works closely with Professor Kim on advancing its HVAC Fault Detection and Diagnostics technology.

In addition, Whisker Labs has developed a new product that sits on breaker panels in homes, installs in minutes, can tell what appliances are running based upon their electronic signatures, and provides detailed insights about a home’s energy usage. The company anticipates that with this new technology, combined with connected thermostats, connected homes, proprietary weather data, home energy score cards and thermodynamic analytics developed with the University of Maryland in the Connected Savings solution, it will become the leading provider of demand-response energy savings in the nation.

We are fortunate to work with a great mechanical engineering group at the University of Maryland. MIPS funding allowed us to get into the market offering a novel approach to demand response challenges. Now that we have data certified by utilities and consumers like us, we are expecting to grow the program into a much larger initiative that will result in more skilled and well-paying jobs here in Maryland. MIPS funding was critical in taking the Connected Savings program from concept to reality.

MIPS Round 

59

February

 

2017

February 1, 2017

HY-TEK Bio, LLC.

Dayton

 | 

Howard

 County

Project:

Increase Methane in Chicken Manure Digesters

Principal Investigator:

Feng
 
Chen
Professor

Technologies:

Agriculture / Poultry Science

Energy

HY-TEK Bio is an early stage company developing a patent-pending system to remove carbon dioxide and other harmful greenhouse gases from smoke stack flue gas using a unique strain of algae while producing valuable byproducts from the algae. The company’s system mitigates greenhouse gas from flue gases by injecting the flue gas into a tank full of a unique strain of algae. The tank is a patent-pending, closed bioreactor produced in-house from a lamination of Mylar and Kevlar. This patent-pending construct allows the bioreactors to be produced inexpensively while being extremely light weight. In addition, patent-pending LED Grow Lights are used along with a nutrient developed in-house, made from fresh chicken manure and a blend of other proprietary components.

The algae feeds on the CO2 and NOx in the flue gas, as well as on the nutrient. CO2 consumption is enhanced through the use of proprietary LED Grow Light technology, yielding minimal greenhouse gas emissions and high yields of high-value algal biomass. The process produces little to no CO2 or NOx emissions, while enhancing the lipid-oil production in the algae as well as a by-product of Lutein-Zeaxanthin, an ultra-antioxidant that is in high demand in the market place. The algal biomass can be sold to brokers, who place the biomass into markets that produce Lutein-Zeaxanthin-based products, bio-plastics, skin care products, cosmetic and paint thickeners, additives for human and animal food products, and biofuel.

We are moving to an entirely new concept in closed bioreactor design using our patentpending Mylar/Kevlar tank structure, our unique “modulated” LED Grow Light technology, our patent-pending air injection system and our special, high-value chicken manurebased nutrient. These concepts will revolutionize closed bioreactors and the way the world mitigates greenhouse gas emissions.
HY-TEK Bio is a classic example of the Maryland Industrial Partnerships Program making a difference in helping a small company bring big ideas to market.

MIPS Round 

59

February

 

2017

February 1, 2017

Paradigm Shift Therapeutics, LLC

Rockville

 | 

Montgomery

 County

Project:

CD47 Inhibitors for Immuno-Oncology Therapy

Principal Investigator:

Elsa
 
Garcin
Associate Professor

Technologies:

Biotechnology / Genetic Engineering

MIPS Round 

59

February

 

2017

February 1, 2017

CoapTech, LLC

Baltimore

 | 

Baltimore City

 County

Project:

Evaluating a Novel Gastrostomy Procedural Method

Principal Investigator:

Richard
 
Wilkerson
Director of Clinical Research

Technologies:

Medical Instrumentation / Equipment

CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound. The company’s CoapTech Carrier™ is a novel platform technology combining magnetic attraction for device placement guidance and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures.

CoapTech is commercializing a kit that will enable clinicians to perform a novel procedural method called Percutaneous Ultrasound Gastrostomy (PUG) for the placement of semi-permanent feeding tubes in the stomach. PUG improves on Percutaneous Endoscopic Gastrostomy (PEG), the current standard of care for feeding tube placement. The company believes that PUG is a safer, simpler, and less expensive method for placing feeding tubes.

MIPS support enables us to bring excellent clinical partners to the table to help plan, prepare, and implement the first human study for our novel device.

MIPS Round 

59

February

 

2017

February 1, 2017

Operational Precision Systems

Salisbury

 | 

Wicomico

 County

Project:

WaterOPS: Safe Drinking Water Compliance Software

Principal Investigator:

Kathie
 
Wright
Associate Professor

Technologies:

Software Development

MIPS Round 

58

October

 

2016

October 1, 2016

Microsphere Material Solutions

Rockville

 | 

Montgomery

 County

Project:

Maturation of Amorphous Glass Foams Manufacturing

Principal Investigator:

Norman
 
Wereley
Minta Martin Professor of Aerospace Engineering

Technologies:

Materials Science

Microsphere Material Solutions LLC is a producer of ultra-high-strength, low-weight materials that provide game-changing capabilities for many applications. Microsphere Material Solutions engages in both the small batch production and research and development of amorphous glass foams for cutting-edge applications. The extraordinary compressive strength-to-weight ratio of amorphous glass foam materials allows for the exploration of new form factors and enhanced capabilities in a wide variety of markets.

Prior to working with Prof. Wereley through MIPS, the company’s product was labscale. The MIPS research enabled Microsphere Material Solutions to make significant progress toward a sellable product by honing the product recipe to the specifications required by submersible and armoring manufacturers. To date, the company has already produced samples with the necessary dimensions for a potential partner in the submersible segment.

Through the research conducted under MIPS, we validated our formulation and radically increased our manufacturing capability. MIPS has provided our company with the catalyst for developing a commercial product derived from lab-scale technology.
Glass syntactic foam is a commonly used material for submersible vehicle buoyancy applications and is one of the limiting factors in creating smaller vehicles due to its lower strength at any given density (syntactic foam consists of glass microspheres bonded with a polymer such as epoxy). MMS’s amorphous glass foam is less dense and stronger at any given depth and enables smaller vehicles to achieve the same depth as larger vehicles. MMS’s foam is composed of only the glass microspheres, with no additional material or additives.

MIPS Round 

58

August

 

2016

August 1, 2016

Millennium Engineering and Integration LLC

Greenbelt

 | 

Prince George’s

 County

Project:

UAV Airborne Intelligent Flight Management System

Principal Investigator:

Huan
 
Xu
Assistant Professor, Aerospace Engineering

Technologies:

Software Development

Millennium Engineering and Integration Company is an employee-owned small business with systems engineering and integration capability in the space, defense, cyber, intelligence, aviation and healthcare markets. The company provides solutions to both the U.S. Government and commercial sectors, solving engineering challenges in satellites, missiles, aircraft, cyber, space resiliency and beyond.

The MIPS project research and testing visibility has enabled Millennium to grow its footprint into the Maryland corridor, particularly leveraging engineering and software expertise to apply to new drone and aerospace systems and customers.

Additional Information:
In 2015, Millennium partnered with Xu to develop an initial set of algorithms and softwarebased simulation of UAV collision avoidance rules and scenarios. Millennium also invested in maritime and in-tunnel UAV surveillance system development.

Millennium has an internal initiative under way to develop UAS/UAV products that enable their safe operation in the NAS. This work has enabled Millennium to provide enhanced flight safety work to NASA, Dryden, and Edwards AFB customers.

This MIPS project is providing Millennium access to an emerging market for means to assure the safety of UAV/UAS operating in the National Air Space (NAS). This new market augments our already strong position in the Space Launch Vehicle, “Return-From-Orbit” and NASA UAV flight test safety assurance marketplaces.

MIPS Round 

58

November

 

2016

November 1, 2016

Badjo-T Industries

Aberdeen

 | 

Wicomico

 County

Project:

The Badjo Suit

Principal Investigator:

Kausiksankar
 
Das
Assistant Professor

Technologies:

Chemical Engineering / Chemistry

Materials Science

MIPS Round 

58

August

 

2016

August 1, 2016

3DBioWorks, Inc

Baltimore

 | 

Baltimore City

 County

Project:

Development of a Bioreactor for Endothelial Cells

Principal Investigator:

John
 
Fisher
Department Chair

Technologies:

Biotechnology / Genetic Engineering

Medical Instrumentation / Equipment

MIPS Round 

58

August

 

2016

August 1, 2016

Tarsier Optics, Inc.

Baltimore

 | 

Baltimore City

 County

Project:

Quantum noise spectrum filter for Quantum Camera

Principal Investigator:

Yan-Hua
 
Shih
Professor of Physics

Technologies:

Image Processing / Pattern Recognition

Tarsier Optics is developing a novel camera system that provides ‘panoramic’ photographs that can resolve micron-level structures at distances of ten miles, independent of the optics. Ultimately, cell phone-like lenses can be used, creating highvalue products in the defense and commercial remote sensing markets, as well as highend consumer segments. Tarsier’s prototype uses “photon counting” and “coincidence counting” measurement devices to capture the data.

In October, 2016, Tarsier received a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to develop a turbulence-free imaging system. In July, 2016, Tarsier received a Maryland Innovation Initiative award.

Tarsier has two full-time employees.

Additional Information:
Tarsier Optics has obtained an exclusive license from UMBC for the patent portfolio covering its camera technology. The inventor was Yanhua Shih.

Competing technologies either use the zoom lenses or try to sharpen images by averaging over frames. The limitation of taking a photograph with a zoom lens is that air turbulence negatively impacts resolution, not the size of the lens. Tarsier will provide a higher-resolution image than a zoom lens, while at the same time not limiting the width of the image to the narrow cone provided by a zoom lens. Using the averaging frames technology is effective at overcoming “camera noise” and other consistent signal disruptions, but does not overcome chaotic turbulence.

Tarsier’s camera finds signal in what is typically perceived to be noise, thus producing high resolution images with the same amount of information currently available to a CCD. Tarsier’s camera creates a single image out of two CCD’s; the novelty lies in how the images are combined. Operationally, the same image, with the same optics, needs to be measured by two CCD’s with a large, angular light source, such as the sun. One CCD captures the image in the same way as a typical camera. The second CCD measures a Fourier transform of the same field of view. Post-processing combines these two data sets or images to output a processed image with a far higher resolution than the optics could have achieved alone.

Because of the MIPS work, we have a fully functional camera that demonstrates all the capabilities we had hoped for. This has enabled us to provide a meaningful value proposition to our customers.

MIPS Round 

58

August

 

2016

August 1, 2016

Sonavex, Inc.

Baltimore

 | 

Baltimore City

 County

Project:

EchoMark Pivotal Safety & Efficacy Porcine Study

Principal Investigator:

Louis
 
DeTolla
Director, Comparative Medicine Program Pathology/Comparative Medicine Program

Technologies:

Medical Instrumentation / Equipment

Sonavex Inc. is a medical device company spun out of Johns Hopkins. The company is dedicated to providing novel ultrasound solutions to visualize and quantify critical data for improved outcomes and reduce costs in new surgical applications. Sonavex developed EchoSure to detect blood clots after surgery to prevent catastrophic surgical failures.

In April, 2017, Sonavex announced that it received $3 million in financing, including the $2.2 million first close of its Series A round. The offering, led by Grey Sky Venture Partners, was expanded by another $1.3 million following increased demand from investors. Other participating investors included CRCM Venture Capital, TEDCO, the Abell Foundation, medical device executives, surgeons and successful business executives.

The company has also secured grants from TEDCO, NIH SBIR, NSF SBIR (Phase I, Phase IB, Phase II), and several competition awards.

Sonavex was named a Maryland 2016 Incubator Company of the Year.

Additional Information:
More than 550,000 procedures each year in reconstructive, transplant, and vascular surgery involve a connection of blood vessels that is necessary to provide blood flow to downstream tissue. Invariably, there is a risk of clot formation. Detecting clot formation in a timely manner allows intervention to remove the clot before it permanently blocks the vessels and is key to preventing catastrophic and expensive surgical failures.

Due to limitations of current modalities, routine monitoring occurs only in the plastic surgery (reconstruction) market, where up to 15 percent of cases will require emergency salvage for clot formation. Delays associated with current monitoring techniques result in a ~50 percent failure rate for salvage attempts. The non-reimbursed financial loss for a hospital ranges between $57,000 and $577,000 per instance, depending on the surgery. (Source: Sonavex)